[Hopespringpcsg] FW: FYI From urotoday.com Topic An increase in Gleason 6 tumour volume while on active surveillance port

[Glen Tolhurst]

Hi all:

Interesting article based on a Canadian study.

Take care,

Glen

 

 


An increase in Gleason 6 tumour volume while on active surveillance portends a greater risk of grade re-classification with further follow-up. <http://www.urotoday.com/2014-09-18-02-47-34/prostate-cancer/83971-an-increase-in-gleason-6-tumour-volume-while-on-active-surveillance-portends-a-greater-risk-of-grade-re-classification-with-further-follow-up.html>  


*	 

Published: 12 October 2015 

 

We evaluated the relative risk of later grade re-classification and outcomes of patients who developed high-volume Gleason 6 prostate cancer (PCa) while on active surveillance (AS).

A prospectively maintained database was used to identify patients on AS between 1998 and 2013.

 

Tumour volume was assessed based on number of positive cores and proportion of core involvement. Chi-square and Fisher's exact test were used for analysis where appropriate. The primary endpoint was development of grade re-classification, defined as grade only and/or grade and volume at the event biopsy.

 

A total of 555 men met study inclusion criteria. Mean follow-up was 46 months. Overall, 70 patients demonstrated an increase in tumour volume at or after their second biopsy (B2). In comparison to those never experiencing volume or grade re-classification, prostate-specific antigen at diagnosis was not significantly different (p=0. 95), but median prostate volume was smaller in patients who demonstrated volume re-classification (p

While Gleason 6 PCa has a favourable natural history, it appears that AS patients who experience volume re-classification are at a substantially higher risk of developing grade re-classification. Thus, urologists should pay close attention to tumour core involvement and monitoring should be adjusted accordingly for early volume re-classification in younger men and in good health.

 

The Journal of urology. 2015 Sep 25 [Epub ahead of print]

Maria Komisarenko, Lih-Ming Wong, Patrick O Richard, Narhari Timilshina, Ants Toi, Andrew Evans, Alexandre Zlotta, Girish Kulkarni, Robert Hamilton, Neil Fleshner, Antonio Finelli

Department of Uro-oncology, Division of Surgical Oncology, Princess Margaret Cancer Center, University Health Network, Toronto, Canada. , Department of Urology, St Vincent's Hospital, Melbourne, Australia, Toronto, Canada. , Department of Uro-oncology, Division of Surgical Oncology, Princess Margaret Cancer Center, University Health Network, Toronto, Canada. , Department of Uro-oncology, Division of Surgical Oncology, Princess Margaret Cancer Center, University Health Network, Toronto, Canada. , Department of Uro-oncology, Division of Surgical Oncology, Princess Margaret Cancer Center, University Health Network, Toronto, Canada. , Department of Pathology, Toronto General Hospital, University of Toronto, Canada, Toronto, Canada. , Department of Uro-oncology, Division of Surgical Oncology, Princess Margaret Cancer Center, University Health Network, Toronto, Canada. , Department of Uro-oncology, Division of Surgical Oncology, Princess Margaret Cancer Center, University Health Network, Toronto, Canada. , Department of Uro-oncology, Division of Surgical Oncology, Princess Margaret Cancer Center, University Health Network, Toronto, Canada. , Department of Uro-oncology, Division of Surgical Oncology, Princess Margaret Cancer Center, University Health Network, Toronto, Canada. , Department of Uro-oncology, Division of Surgical Oncology, Princess Margaret Cancer Center, University Health Network, Toronto, Canada. 

 

 

 

 

url:http://www.urotoday.com/index.php?option=com_content <url:http://www.urotoday.com/index.php?option=com_content&view=article&id=83971:an-increase-in-gleason-6-tumour-volume-while-on-active-surveillance-portends-a-greater-risk-of-grade-re-classification-with-further-follow-up&catid=1134:prostate-cancer&Itemid=782&utm_source=newsletter_3049&utm_medium=email&utm_campaign=uroalerts-prostate-cancer-weekly> &view=article&id=83971:an-increase-in-gleason-6-tumour-volume-while-on-active-surveillance-portends-a-greater-risk-of-grade-re-classification-with-further-follow-up&catid=1134:prostate-cancer&Itemid=782&utm_source=newsletter_3049&utm_medium=email&utm_campaign=uroalerts-prostate-cancer-weekly

-- 
You received this message because you are subscribed to the Google Groups "FYI Prostate Info" group.
To unsubscribe from this group and stop receiving emails from it, send an email to fyi-prostate-info+unsubscribe at googlegroups.com.
To post to this group, send email to fyi-prostate-info at googlegroups.com.
To view this discussion on the web visit https://groups.google.com/d/msgid/fyi-prostate-info/d4517eef-a8c6-4864-984c-1368dc4cf163%40googlegroups.com <https://groups.google.com/d/msgid/fyi-prostate-info/d4517eef-a8c6-4864-984c-1368dc4cf163%40googlegroups.com?utm_medium=email&utm_source=footer> .
For more options, visit https://groups.google.com/d/optout.

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://artsservices.uwaterloo.ca/pipermail/hopespringpcsg/attachments/20151019/251a30cc/attachment.html>